Published in Arch Gen Psychiatry on January 01, 1974
Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression. Psychol Bull (2008) 2.24
Distinctions between bipolar and unipolar depression. Clin Psychol Rev (2005) 1.42
Brain substrates of behavioral programs associated with self-regulation. Front Psychol (2010) 0.88
Review of the pharmacology of existing antidepressants. Br J Clin Pharmacol (1977) 0.86
5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology. Br J Clin Pharmacol (1983) 0.83
Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. J Psychiatry Neurosci (2007) 0.82
5-Hydroxytryptamine and dopamine pathways in mania: a pilot study of fenfluramine and pimozide. Br J Clin Pharmacol (1976) 0.77
Effect of lithium on behavioral disinhibition induced by electrolytic lesion of the median raphe nucleus. Psychopharmacology (Berl) (2014) 0.76
[Bipolar disorder in childhood and adolescence]. Rev Bras Psiquiatr (2004) 0.75
Neurochemical and psychoanalytical approaches to mania. Proc R Soc Med (1977) 0.75
Methylene blue and its analogues as antidepressant compounds. Metab Brain Dis (2017) 0.75
Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med (1999) 2.72
Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci U S A (1979) 2.43
Oxytocin induces maternal behavior in virgin female rats. Science (1982) 2.23
Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry (1993) 1.78
A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch Gen Psychiatry (1981) 1.49
Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis (1997) 1.36
Effects of thyrotropin-releasing hormone in depression. Lancet (1972) 1.34
Thyrotropin releasing hormone: enhancement of dopa activity by a hypothalamic hormone. Science (1972) 1.31
Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature (1976) 1.29
Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch Gen Psychiatry (1969) 1.24
Abnormalities of indoleamines in affective disorders. Arch Gen Psychiatry (1972) 1.20
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry (1982) 1.19
Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry (1982) 1.13
Oxytocin facilitates the sexual receptivity of estrogen-treated female rats. Neuropeptides (1986) 1.12
Borderline hypothyroidism and depression. Annu Rev Med (1995) 1.08
Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther (1983) 1.05
Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry (1969) 1.04
Neurotensin blocks certain amphetamine-induced behaviours. Nature (1981) 1.02
Oxytocin antiserum delays onset of ovarian steroid-induced maternal behavior. Neuropeptides (1985) 1.01
Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res (1977) 1.01
A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci (1996) 0.99
Neurotensin, a biologically active peptide. Life Sci (1978) 0.99
Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine. Proc Natl Acad Sci U S A (1979) 0.98
Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J Pharmacol Exp Ther (1975) 0.97
The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry (1972) 0.96
Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience (1983) 0.96
The effect of neurotensin on food consumption in the rat. Eur J Pharmacol (1982) 0.95
Oxytocin and vasopressin immunoreactivity in hypothalamic and extrahypothalamic sites in late pregnant and postpartum rats. Neuroendocrinology (1987) 0.94
Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience (1984) 0.92
Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment. Am J Psychiatry (1982) 0.92
Thydrotropin releasing hormone: antagonism of pentobarbital in rodents. Life Sci (1974) 0.91
Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand (1988) 0.91
Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin). Arch Gen Psychiatry (1979) 0.90
Methyltestosterone with imipramine in men: conversion of depression to paranoid reaction. Am J Psychiatry (1974) 0.89
Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH). J Pharmacol Exp Ther (1976) 0.89
Cytoprotective effect of centrally administered neurotensin on stress-induced gastric ulcers. Am J Physiol (1982) 0.89
Peptides and psychoneuroendocrinology. A perspective. Arch Gen Psychiatry (1978) 0.88
THR (lopremone): psychobiological responses of normal women. I. Subjective experiences. Arch Gen Psychiatry (1973) 0.88
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. J Pharmacol Exp Ther (1983) 0.88
Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. Science (1983) 0.88
Effects of thyrotropin-releasing hormone on locomotor activity, operant performance and ingestive behavior. J Pharmacol Exp Ther (1979) 0.87
Cognitive impairment in patients with multiple sclerosis and mild physical disability. Arch Neurol (1987) 0.87
Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone. J Pharmacol Exp Ther (1981) 0.87
Oxytocin potently enhances novelty-induced grooming behavior in the rat. Brain Res (1986) 0.87
Antagonism of ethanol narcosis by thyrotropin releasing hormone. Life Sci (1974) 0.87
Cyclic A.M.P. in affective disorders. Lancet (1970) 0.87
The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain. Psychoneuroendocrinology (1987) 0.87
The role of the adrenal gland in cytoprotection against stress-induced gastric ulcers in rats. J Neurosci Res (1984) 0.86
Peptides and nociception. Int Rev Neurobiol (1984) 0.86
Cholecystokinin inhibits tail pinch-induced eating in rats. Science (1978) 0.86
Pharmaco-behavioral effects of hypothalamic peptides in animals and man: focus on thyrotropin-releasing hormone and neurotensin. Psychoneuroendocrinology (1978) 0.86
Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg (1994) 0.86
Methysergide in mania. A controlled trial. Lancet (1969) 0.85
Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine. Am J Psychiatry (1982) 0.85
Interactions of neurotensin with brain dopamine systems. Ann N Y Acad Sci (1982) 0.85
Growth, endocrinological and behavioral deficits after monosodium L-glutamate in the neonatal rat: possible involvement of arcuate dopamine neuron damage. Psychoneuroendocrinology (1977) 0.85
The two-type thesis of depressive disorders. Am J Psychiatry (1966) 0.84
The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis. Pharmacol Ther (2008) 0.84
Catecholamines: diminished rate of synth- esis in rat brain and heart after thyroxine pretreatment. Life Sci I (1970) 0.84
Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression. J Psychiatr Res (1972) 0.83
Inefficacy of tryptophan-pyridoxine in essential tremor. Lancet (1971) 0.83
Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions. Med Hypotheses (2007) 0.82
Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. J Neuropsychiatry Clin Neurosci (1989) 0.82
Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area. Brain Res (1981) 0.82
3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine. Nat New Biol (1972) 0.82
Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur J Pharmacol (1982) 0.82
Thyroid function and the response to liothyronine in depression. Arch Gen Psychiatry (1972) 0.82
Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat. Pharmacol Biochem Behav (1986) 0.82
Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings. Biol Psychiatry (1991) 0.82
Effects of a very low calorie diet on weight, thyroid hormones and mood. Int J Obes (1990) 0.81
Interactive effects of intracisternal oxytocin and other centrally active substances on colonic temperatures of mice. Regul Pept (1986) 0.81
Thyrotropin releasing hormone: enhancement of DOPA activity in thyroidectomized rats. Life Sci (1974) 0.81
L-triiodothyronine: is this peripheral hormone a central neurotransmitter? Neuropsychopharmacology (1993) 0.81
Long-term predictors of outcome in abstinent alcoholic men. Am J Psychiatry (1990) 0.81
Effects of imipramine and thioridazine on set and attention. Dis Nerv Syst (1966) 0.80
The prolactin response to thyrotropin-releasing hormone in depressed patients and normal subjects. Psychoneuroendocrinology (1986) 0.80
Centrally administered neurotensin: activity in the Julou-Courvoisier muscle relaxation test in mice. Eur J Pharmacol (1979) 0.80
Chronic dopa treatment: effect on the concentration of norepinephrine in the hearts and brains of rats. Eur J Pharmacol (1971) 0.80
Thyrotropin releasing hormone (TRH): a useful tool for psychoneuroendocrine investigation. Psychoneuroendocrinology (1980) 0.80
The effects of neurotensin, beta-endorphin, and bombesin on ethanol-induced behaviors in mice. Psychopharmacology (Berl) (1983) 0.80
Prevention of stress-induced gastric ulcers by dopamine agonists in the rat. Life Sci (1984) 0.80
Human brain distribution of neurotensin in normals, schizophrenics, and Huntington's choreics. Ann N Y Acad Sci (1982) 0.80
A comparison of grooming behavior potencies of neurohypophyseal nonapeptides. Regul Pept (1986) 0.80
The effect of drug exposure on thyroid hormone levels of newborns. Biochem Med Metab Biol (1992) 0.80
Evidence for biological activity of two N-terminal fragments of neurotensin, neurotensin1-8 and neurotensin1-10. Brain Res (1984) 0.79